US Task Force Releases Recommendations for Prostate Cancer Screening

May 08, 2018

|

NEW YORK (360Dx) – The US Preventive Services Task Force said today that men aged 55 to 59 should decide with their clinicians whether to pursue prostate specific antigen-based cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

US Task Force Releases Recommendations for Prostate Cancer Screening

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

4D Path Prepping FDA Submission for AI-Enabled Breast Cancer Digital Pathology Product

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

Sponsorships